What statements about infliximab therapy is incorrect?

Infliximab therapy is indicated for treating:

A. Rheumatoid arthritis

B. Crohn’s disease

C. Crohn’s proctitis

D. Acute sinusitis

The correct answer is D. Acute sinusitis.

Infliximab (Remicade®) is a tumor necrosis factor alpha (TNF-α) inhibitor. It is indicated for reducing signs and symptoms, inducing and maintaining clinical remission, and preventing structural damage in patients with moderately to severely active Crohn’s disease or with fistulizing Crohn’s disease, when patients have had an inadequate response to conventional therapy.*